This post examines a growing COVID-19 vaccine gap in Red and Blue America, with the share of the population that have been fully vaccinated in counties that voted for President Biden in 2020 increasing more rapidly than the share in counties that voted for President Trump.
- view as grid
- view as list
In response to prescription drug spending growth and heightened attention to drug prices, some policymakers have proposed allowing the federal government to negotiate the price of prescription drugs for Medicare and private payers. This brief describes the current status of drug price negotiation proposals, looks back at the history of proposals to give the federal government the authority to negotiate drug prices in Medicare, describes the negotiation provisions in key legislation (H.R. 3), and discusses the potential spending effects for the federal government, beneficiaries, and private payers.
Two-Thirds of the Public Say the U.S. Should Play a Major Role in Distributing COVID-19 Vaccines Globally, But Not Most Republicans
With increased attention to the global need for COVID-19 vaccines and the Biden administration’s announcement today about how it plans to distribute the first portion of the 80 million doses it will share by the end of this month, the latest KFF Health Tracking Poll finds that two-thirds of the…
The latest KFF Health Tracking Poll explores the public’s views on the U.S. role in distributing COVID vaccines to other countries, health care priorities for Congress, prescription drug regulations and price negotiations, and affordability changes in the COVID-19 relief bill.
In this column for the JAMA Health Forum, Larry Levitt examines the implications of lowering Medicare’s age of eligibility, which is emerging as a potential pathway toward Medicare-for-all or a public option among single-payer advocates. He explores the implications for costs, industry, people and broader reform efforts.
This 2021 analysis goes back into the data we collected in interviews with a random sample of registered voters in three Sun Belt states (Arizona, Florida, and North Carolina) and matches it with actual voter records from Election Day to better understand the demographics of voters who cast ballots in the 2020 election and whether their views and experiences were different than those who chose to not vote.
Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink
Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to grow, with roughly 6 in…
This Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. It explores vaccine intentions, information gaps, vaccine brand preferences, and tests a variety of potential incentives, messages, and pieces of information that might be used to increase vaccination uptake.
KFF COVID-19 Vaccine Monitor Probes Americans’ Experiences Trying to Sign Up for a Vaccine and to Find Relevant Information
Many Relied on Another Person’s Help to Try to Get a Vaccine Appointment As many states and local authorities ramp up their COVID-19 vaccination efforts, the latest KFF COVID-19 Vaccine Monitor report provides the first in-depth look at Americans’ experiences trying to gather relevant information and sign up to get…
This report shows about half over the age of 65 say they have already received at least one dose of the vaccine or have scheduled an appointment to do so. It also examines how easy or difficult it has been for people to get an appointment and information about the vaccine, and where the public would most like to receive it.